Impact of systemic resveratrol on non-surgical periodontal treatment of smokers: A 12-month randomized clinical trial.
- 2025-08-30
- RCT · n = 19
- Clinical oral investigations 29(9)
- Vanessa Haguihara Lucchesi
- Ana Paula Oliveira Giorgetti
- Mônica Grazieli Corrêa
- Vanessa G A Pecorari
- Bruno Braga Benatti
- Howard C Tenenbaum
- Fabiano Ribeiro Cirano
- Suzana Peres Pimentel
- Márcio Zafallon Casati
- PubMed: 40884630
- DOI: 10.1007/s00784-025-06517-9
- High evidence
- Clinical
RSV appeared to induce lower PD [2.96 (0.41) - 3 months; 2.85 (0.40) - 6 months; 2.80 (0.35)- 12 months] ... as compared to Placebo [PD: 3.22 (0.51) - 3 months; 3.07 (0.42) - 6 months; 3.02 (0.42) - 12 months] throughout the time (p < 0.05).
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 500 mg/day